Literature DB >> 19447627

Murine double minute 2: p53-independent roads lead to genome instability or death.

Alyssa Bouska1, Christine M Eischen.   

Abstract

The oncoprotein murine double minute 2 (Mdm2) is frequently overexpressed in many types of human malignancies. Although Mdm2 has an essential role in negatively regulating the p53 tumor suppressor, it also has less well characterized p53-independent functions that influence pathways that are crucial for controlling tumorigenesis. In addition to the impact Mdm2 has on p53-independent apoptosis, mounting evidence is linking increased Mdm2 levels to altered cell-cycle regulation, DNA replication and DNA repair leading to loss of genome stability. Mdm2 involvement in pathways that influence chromosome stability and cell death, distinct from its role in the p53 pathway, strengthens the position of Mdm2 as a desirable therapeutic target for the treatment of human cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447627     DOI: 10.1016/j.tibs.2009.02.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  32 in total

1.  CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability.

Authors:  Anne-Sophie Huart; Nicola J MacLaine; David W Meek; Ted R Hupp
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

Review 2.  Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

Authors:  Amanda R Wasylishen; Guillermina Lozano
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

3.  MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Authors:  Qian Bi; Atul Ranjan; Rui Fan; Neeraj Agarwal; Danny R Welch; Steven A Weinman; Jie Ding; Tomoo Iwakuma
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

4.  MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53.

Authors:  Wei Wang; Jian-Wen Cheng; Jiang-Jiang Qin; Bo Hu; Xin Li; Bhavitavya Nijampatnam; Sadanandan E Velu; Jia Fan; Xin-Rong Yang; Ruiwen Zhang
Journal:  Cancer Lett       Date:  2019-06-07       Impact factor: 8.679

5.  Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.

Authors:  J C Senturk; S Bohlman; J J Manfredi
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

6.  Mdm2 is a target and mediator of IRP2 in cell growth control.

Authors:  Jin Zhang; Xiangmudong Kong; Yanhong Zhang; Wenqiang Sun; Enshun Xu; Xinbin Chen
Journal:  FASEB J       Date:  2019-12-12       Impact factor: 5.191

7.  Association between murine double minute 2 T309G polymorphism and risk of liver cancer.

Authors:  Tao Tang; Xin Song; Zhiying Yang; Linping Huang; Wenyue Wang; Haidong Tan
Journal:  Tumour Biol       Date:  2014-08-14

8.  The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Kalkunte S Srivenugopal; Subhasree Nag; Shivaputra Patil; Horrick Sharma; Ming-Hai Wang; Hui Wang; John K Buolamwini; Ruiwen Zhang
Journal:  Nat Commun       Date:  2014-10-01       Impact factor: 14.919

9.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

10.  MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.

Authors:  Magdalena Wienken; Antje Dickmanns; Alice Nemajerova; Daniela Kramer; Zeynab Najafova; Miriam Weiss; Oleksandra Karpiuk; Moustapha Kassem; Yanping Zhang; Guillermina Lozano; Steven A Johnsen; Ute M Moll; Xin Zhang; Matthias Dobbelstein
Journal:  Mol Cell       Date:  2015-12-31       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.